Drug Information

Drug General Information
Drug ID
D0A8HX
Former ID
DNC012800
Drug Name
6-m-Tolyl-pteridine-2,4,7-triamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526601]
Formula
C13H13N7
Canonical SMILES
CC1=CC=CC(=C1)C2=NC3=C(N=C2N)N=C(N=C3N)N
InChI
1S/C13H13N7/c1-6-3-2-4-7(5-6)8-10(14)18-12-9(17-8)11(15)19-13(16)20-12/h2-5H,1H3,(H6,14,15,16,18,19,20)
InChIKey
YCKFHKBIDNIARX-UHFFFAOYSA-N
PubChem Compound ID
227595
Target and Pathway
Target(s) Dihydrofolate reductase Target Info Inhibitor [526601]
PathWhiz Pathway Folate Metabolism
Pterine Biosynthesis
Reactome E2F mediated regulation of DNA replication
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
Metabolism of folate and pterines
G1/S-Specific Transcription
References
Ref 526601J Med Chem. 2003 Apr 24;46(9):1726-36.Further studies on 2,4-diamino-5-(2',5'-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS.
Ref 526601J Med Chem. 2003 Apr 24;46(9):1726-36.Further studies on 2,4-diamino-5-(2',5'-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS.